← Back to Patent Explorer
US5069906A Expired / Lapsed US ⏱️ 0.0 years remaining

Intra-vaginal device and method

Assignee: BELMAC/MAXIMED PARTNERSHIP
•
Filing: 1990-12-11
•
Granted: 1991-12-03
•
Expires: 2010-12-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention disclosed provides an intra-vaginal device prepared using ingredients which slowly release in the vagina over a significant period of time. The present intra-vaginal device also usefully serves as a drug release means for controllably releasing a drug in the vagina. A method for controlled drug release in the vagina is also disclosed.

Inventors

  • 👤 Robert S. Cohen
  • 👤 James M. Pierce
  • 👤 William H. Kinsey

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:48
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0034

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 97 words
A solidified gel composition suitable for use as an intra-vaginal insert, capable of dissolution or disintegration in the presence of vaginal fluids and consisting essentially of an aqueous saline solution containing a gelling agent dissolved or dispersed therein, said gelling agent being selected from the group consisting of agarose or agar, glycosaminoglycan, collagen, carageen or carageenan, locust bean gum, fibrin and glycerin, and an enzyme selected from the group consisting glycerine, protease, agarase, collagenase and saccharidase, said gelling agent and said enzyme being present in said composition in minor amounts totaling less than fifty percent by weight.
Claim 2
Dependent Claim 97 words
A solidified gel composition suitable for use as an intra-vaginal insert, capable of dissolution or disintegration in the presence of vaginal fluids and consisting essentially of an aqueous saline solution containing a gelling agent dissolved or dispersed therein, said gelling agent being selected from the group consisting of agarose or agar, glycosaminoglycan, collagen, carageen or carageenan, locust bean gum, fibrin and glycerin, and an enzyme selected from the group consisting glycerine, protease, agarase, collagenase and saccharidase, said gelling agent and said enzyme being present in said composition in minor amounts totaling less than fifty percent by weight.
Claim 3
Dependent Claim 33 words
A composition in accordance with claim 1 wherein said composition additionally contains an effective amount of an additive selected from the group consisting of an antimicrobial, an antifungal, a virucide and a spermicide.

References Cited (Backward Citations)

US3493652A Cited
US4381772A Cited
US4707362A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-12-02 1995-06-03 1995-12-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-12-02 1999-06-03 1999-12-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-12-02 2003-06-03 2003-12-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag